These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9717552)

  • 1. [Radiometabolic therapy: dose equivalents from external exposure and internal contamination].
    Scielzo G; Rivolta A
    Radiol Med; 1998 Jun; 95(6):663-8. PubMed ID: 9717552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.
    Boice JD; Leggett RW; Ellis ED; Wallace PW; Mumma M; Cohen SS; Brill AB; Chadda B; Boecker BB; Yoder RC; Eckerman KF
    Health Phys; 2006 May; 90(5):409-30. PubMed ID: 16607174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technologist radiation exposure in routine clinical practice with 18F-FDG PET.
    Guillet B; Quentin P; Waultier S; Bourrelly M; Pisano P; Mundler O
    J Nucl Med Technol; 2005 Sep; 33(3):175-9. PubMed ID: 16145226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurements of long-term external and internal radiation exposure of inhabitants of some villages of the Bryansk region of Russia after the Chernobyl accident.
    Bernhardsson C; Zvonova I; Rääf C; Mattsson S
    Sci Total Environ; 2011 Oct; 409(22):4811-7. PubMed ID: 21906781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applicability test of methods for discrimination between external and internal contamination using an ORTEC whole body counter.
    Ko JH; Kong TY; Akabani G; Kim HG; Lee GJ
    Radiat Prot Dosimetry; 2014 Dec; 162(4):657-62. PubMed ID: 24648259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [External exposure of hot cell operators in nuclear medicine].
    Sichirollo AE; Bombardieri E; Cortona G; Marchesini R
    Radiol Med; 1998 Dec; 96(6):612-7. PubMed ID: 10189927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Method of patient dose evaluation in the angiographic and interventional radiology procedures.
    Rivolta A; Emanuelli S; Tessarin C; Bresciani S; Genovese MG; Rogge D; Scielzo G
    Radiol Med; 2005; 110(5-6):689-98. PubMed ID: 16437054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: study of errors in dosimetry.
    Thierry-Chef I; Marshall M; Fix JJ; Bermann F; Gilbert ES; Hacker C; Heinmiller B; Murray W; Pearce MS; Utterback D; Bernar K; Deboodt P; Eklof M; Griciene B; Holan K; Hyvonen H; Kerekes A; Lee MC; Moser M; Pernicka F; Cardis E
    Radiat Res; 2007 Apr; 167(4):380-95. PubMed ID: 17388692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose to fingertips of staff preparing stranded iodine-125 seeds for permanent prostate implants.
    van Haaren PM; van't Riet A; Moerland MA; Koedooder C; Westendorp H
    Radiat Prot Dosimetry; 2011 Apr; 145(1):61-5. PubMed ID: 21112885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The overview of internal exposure monitoring in Lithuania.
    Griciene B; Ladygiene R; Morkunas G; Pilkyte L; Urboniene A
    Radiat Prot Dosimetry; 2007; 127(1-4):398-401. PubMed ID: 17827133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of voxel phantoms in whole-body counting for the validation of calibration phantoms and the assessment of uncertainties.
    de Carlan L; Roch P; Blanchardon E; Franck D
    Radiat Prot Dosimetry; 2007; 125(1-4):477-82. PubMed ID: 17018545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on internal exposure doses received by the cuban population due to the intake of radionuclides from the environmental sources.
    Tomás Zerquera J; Prendes Alonso M; Fernández Gómez IM; Rodríguez Castro GV; Martínez Ricardo N; López Bejerano G; Ara do López JO; Acosta Rodríguez N; Carrazana González J; Brígido Flores O; Hernández Pérez A; Díaz Rizo O
    Radiat Prot Dosimetry; 2006; 121(2):168-74. PubMed ID: 16513820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of internal exposure of nuclear medicine staff through in vivo and in vitro bioassay techniques.
    Lucena EA; Rebelo AM; Araújo F; Sousa WO; Dantas AL; Dantas BM; Corbo R
    Radiat Prot Dosimetry; 2007; 127(1-4):465-8. PubMed ID: 17681960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutron activation of patients following boron neutron capture therapy of brain tumors at the high flux reactor (HFR) Petten (EORTC Trials 11961 and 11011).
    Wittig A; Moss RL; Stecher-Rasmussen F; Appelman K; Rassow J; Roca A; Sauerwein W
    Strahlenther Onkol; 2005 Dec; 181(12):774-82. PubMed ID: 16362787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How conservative is routine personal dosimetry monitoring in diagnostic radiology?].
    von Boetticher H; Lachmund J; Hoffmann W
    Rofo; 2007 Jul; 179(7):728-32. PubMed ID: 17657704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital discharge of patients with thyroid carcinoma treated with 131I.
    Venencia CD; Germanier AG; Bustos SR; Giovannini AA; Wyse EP
    J Nucl Med; 2002 Jan; 43(1):61-5. PubMed ID: 11801704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of intake and internal dose from iodine-131 for exposed workers handling radiopharmaceutical products.
    Bitar A; Maghrabi M; Doubal AW
    Appl Radiat Isot; 2013 Dec; 82():370-5. PubMed ID: 24184740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation exposure after permanent prostate brachytherapy.
    Cattani F; Vavassori A; Polo A; Rondi E; Cambria R; Orecchia R; Tosi G
    Radiother Oncol; 2006 Apr; 79(1):65-9. PubMed ID: 16564593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation dose to PET technologists and strategies to lower occupational exposure.
    Roberts FO; Gunawardana DH; Pathmaraj K; Wallace A; U PL; Mi T; Berlangieri SU; O'Keefe GJ; Rowe CC; Scott AM
    J Nucl Med Technol; 2005 Mar; 33(1):44-7. PubMed ID: 15731021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.
    Matthay KK; Panina C; Huberty J; Price D; Glidden DV; Tang HR; Hawkins RA; Veatch J; Hasegawa B
    J Nucl Med; 2001 Nov; 42(11):1713-21. PubMed ID: 11696644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.